Are there better alternatives to Ozempic with Sami Inkinen, CEO of Virta Health
This week on Second Opinion, we're featuring Christina Farr, Ash Zenooz, and Luba Greenwood's conversation with Sami Inkinen, CEO of Virta Health.
Podcast
Why health care entrepreneurs need to be missionaries, not mercenaries — with angel investor Zen Chu
This week on Second Opinion, Christina Farr sits down with healthcare investing legend Zen Chu, who shares his framework for backing resilient entrepreneurs and insights from early investments in companies like Abridge and PillPack.
Distribution advantage: Are influencers the new moat in healthcare? with Headline VC's Georgina McMillan
The week on Second Opinion, Christina Farr and Luba Greenwood sit down with Georgina McMillan to discuss the impact of
Let's talk about men's health: hormones, longevity, and cultural shifts, with Hone CEO Saad Alam
In this episode of Second Opinion, Christina Farr and Luba Greenwood discuss men's health with Saad Alam, co-founder and CEO of Hone Health.
Dr. Dean Ornish proved heart disease Is reversible. Now he's doing it with Alzheimer's
What Dr. Dean Ornish is showing the establishment about disease reversal
Why healthcare needs more rule breakers with Jonathan Bush, CEO of Zus Health
Luba Greenwood and Ash Zenooz interview Jonathan Bush. Jonathan is the CEO of a16z-backed Zus Health, Executive Chairman of Firefly Health and a co-founder of Athena Health.
The $1M patient keeping employers up at night w/ Lantern CEO John Zutter & Matt Harmon
In this episode of Second Opinion, Christina Farr is joined by John Zutter, CEO of Lantern, and Matt Harmon, a long time benefits executive who's worked at fortune 100 companies to discuss the rising costs of healthcare, focusing on how large employers are addressing the financial impacts of tre
The $500 billion healthcare problem nobody talks about w/ Mike Desjadon, CEO of Anomaly Health
In this episode of Second Opinion, Christina Farr and Luba Greenwood chat with Mike Desjadon, CEO of Anomaly Health, about the state of American healthcare heading into 2025.
Why healthcare innovation can't wait for politics with Andrea Ippolito, CEO of SimpliFed
Ash Zenooz and Luba Greenwood interview Andrea Ippolito about her extensive career in healthcare spanning academia, government, and the private sector, as well as her current role as founder and CEO of SimpiFed. They discuss the intricacies of government roles, the importance of women's health, and
The biotech reset
Luba Greenwood and Ash Zenooz discuss the evolving biotech landscape, the impact of AI on drug discovery, the importance of using real-world evidence in drug development, and personal motivations for continuing efforts in the biotech field.
Future of American healthcare: post-election with Zeke Emanuel
Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Zeke Emanuel, a prominent oncologist, bioethicist, and influential voice in healthcare to discuss the impact of GLP-1 drugs, healthcare affordability, Trump's appointments, and AI in medicine. The second half of the episode was recorded a
Why healthcare is losing its women CEOs
Christina Farr and Ash Zenooz discuss the recent departures of prominent female CEOs from major healthcare companies and explore why progress in female leadership representation has been challenging in the healthcare industry.